4//SEC Filing
Weiland Robert J. 4
Accession 0001333277-18-000032
CIK 0001042074other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 5:46 PM ET
Size
5.3 KB
Accession
0001333277-18-000032
Insider Transaction Report
Form 4
Weiland Robert J.
Director
Transactions
- Award
Stock Option (right to buy)
2018-01-24+16,000→ 16,000 totalExercise: $11.69Exp: 2028-01-23→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the underlying shares monthly beginning January 1, 2018.
Documents
Issuer
CymaBay Therapeutics, Inc.
CIK 0001042074
Entity typeother
Related Parties
1- filerCIK 0001670648
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 5:46 PM ET
- Size
- 5.3 KB